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Summary
Reprogramming of a differentiated cell back to a naive
pluripotent identity is thought to occur by several indepen-
dent mechanisms. Two such mechanisms include NANOG
and activated STAT3 (pSTAT3), known master regulators of
naive pluripotency acquisition [1–5]. Here, we investigated
the relationship between NANOG and pSTAT3 during the
establishment and maintenance of naive pluripotency. Sur-
prisingly, we found that NANOG enhances LIF signal trans-
duction, resulting in elevated pSTAT3. This is mediated, at
least in part, by suppression of the expression of the
LIF/STAT3 negative regulator SOCS3. We also discovered
NANOG to be limiting for the expression of KLF4, a canonical
‘‘Yamanaka’’ reprogramming factor [6] and key pSTAT3
target [2, 7, 8]. KLF4 expression resulted from the codepen-
dent and synergistic action of NANOGand pSTAT3 in embry-
onic stem cells and during initiation of reprogramming.
Additionally, within 48 hr, the combined actions of NANOG
and pSTAT3 in a reprogramming context resulted in reacti-
vation of genes associated with naive pluripotency. Impor-
tantly, we show that NANOGcan be bypassed during reprog-
ramming by exogenous provision of its downstream
effectors, namely pSTAT3 elevation and KLF4 expression.
In conclusion, we propose that mechanisms of reprogram-
ming are linked, rather than independent, and are centered
on a small number of genes, including NANOG.Results
NANOG Amplifies STAT3 Activation
We first investigated the effect of NANOG on STAT3 activation
in embryonic stem cells (ESCs), since the pluripotency
network is established and functional in this cellular context.
Although NANOGand STAT3 are essential for embryonic naive
pluripotency establishment [4, 9], they promote but are not
required for in vitro ESC maintenance [10–14]. This permits*Correspondence: jcs64@cscr.cam.ac.uk
This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution,
and reproduction in any medium, provided the original author and source
are credited.the study ofNanog2/2 and Stat32/2 ESCs and suggests differ-
ences between network requirements for naive pluripotency
establishment versus maintenance.
Active pSTAT3 lies downstream of a LIF-stimulated tyrosine
kinase signaling cascade [1] (Figure S1A available online).
Wild-type,Nanog2/2, and constitutively NANOG-overexpress-
ing ESCs were harvested from steady-state and LIF-induction
cultures. Western blotting revealed that higher NANOG both
increased steady-state pSTAT3 levels (Figures 1A and S1B)
and enhanced ESC sensitivity to LIF stimulation (Figure 1B).
To explain how NANOG drives pSTAT3 elevation without
directly binding the STAT3 protein or gene [17, 18], we exam-
ined the effect of NANOG on components of the LIF/STAT3
signaling pathway (Figure S1A). By quantitative RT-PCR
(qRT-PCR), no correlation was reliably found between NANOG
and transcript levels of the positive signal transducers Lif, Lifr,
Gp130, Jak2, and Stat3 (data not shown), despite NANOG
binding to Lif, Lifr, and Gp130 gene regulatory sequences in
ESCs according to published chromatin immunoprecipitation
sequencing data [18]. However, NANOG also binds the
Socs3 gene (Figure S1C), which is a negative regulator of
STAT3 activation [19, 20]. This prompted our hypothesis that
NANOG represses Socs3 transcription.
Since Socs3 transcription is upregulated by pSTAT3 to form
a classic negative feedback loop [20, 21], determination of
whether NANOG causes Socs3 repression is obfuscated by
the effect of pSTAT3 on Socs3. To disentangle the opposing
yet interconnected influences of NANOG and pSTAT3 on
Socs3 expression, we designed experiments in which the
pSTAT3 level is not significantly influenced by NANOG. ESCs
can be maintained without exogenous LIF by 2i medium [10],
which contains small molecules CHIR99021 (chiron) and
PD0325901 (PD03) that inhibit GSK3 and MEK, respectively.
In the absence of LIF-stimulated Socs3 activation, the effect
of NANOG on Socs3 transcription can be assessed. From
qRT-PCR analysis of wild-type, Nanog2/2, and constitutively
NANOG-overexpressing ESCs cultured in 2i, a strong negative
correlation was evident betweenNanog and Socs3 expression
levels (Figure 1C). Furthermore, in the absolute absence of
pSTAT3 in Stat32/2 ESCs, those constitutively overexpressing
NANOG exhibited a lower Socs3 level (Figure 1C).
STAT3 can be specifically activated by GCSF stimulation of
the GY118F receptor transgene [22–24] (Figure S1A). When
GCSF/GY118F are used in the absence of LIF, Socs3 downre-
gulation by NANOG should have little or no effect on pSTAT3
levels; GY118F is insensitive to SOCS3 repression, and nearly
all STAT3 activation will be attributable to GY118F rather than
LIFR-GP130. In addition, we generated a doxycycline (dox)-
inducible Nanog transgene (iNANOG) (Figure S1D). Dox induc-
tion of NANOG expression rapidly led to enriched NANOG
binding at the Socs3 gene in ESCs, consistent with direct tran-
scriptional regulation (Figure S1C). InNanog2/2 ESCs contain-
ing both iNANOG and GY118F, NANOG expression and STAT3
activation were induced separately and in combination in 2i.
Induction of NANOG alone caused Socs3 repression, while
Socs3 induction in response to STAT3 activation was reduced
by 60% when NANOG was also induced (Figure 1D). This sug-
gests that Socs3 repression is a mechanism by which NANOG
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Figure 1. NANOG Amplifies STAT3 Activation
(A) Western blot analysis of pSTAT3, total STAT3, and KLF4 protein expression in Nanog2/2 and constitutively NANOG-overexpressing ESCs cultured in
steady-state serum+LIF conditions and harvested on two separate days (i and ii). OCT4 expression confirmed undifferentiated status.
(B) Western blot analysis of pSTAT3 and total STAT3 protein expression in wild-type, constitutively NANOG-overexpressing, and Nanog2/2 ESCs in
response to LIF stimulation for 0, 2, and 12 hr. Positive feedback of pSTAT3 induction on STAT3 and NANOG expression was observed, in accordance
with previous work [2, 7, 15]. Selection for pluripotent cells was maintained throughout. Left: LIF was withdrawn from serum+LIF culture for 36 hr prior
to readdition. Right: ESCs were cultured in 2i for at least 7 days prior to LIF addition. Different conditions were used to provide the most informative com-
parisons, since 2i boosts the expression of endogenous NANOG compared to serum conditions [16].
(C and D) qRT-PCR analysis of gene expression, relative toGapdh and normalized either to the highest value (C) or to serum+LIF ESC level (D). Data shown
are the mean of three technical replicates and are from one of two representative experiments. Error bars indicate 6SD.
(C) Nanog and Socs3 expression in ESCs cultured in 2i without LIF for at least 7 days. Top: Nanog2/2, wild-type, and constitutively NANOG-overexpressing
ESCs. Bottom: control and NANOG-overexpressing Stat32/2 ESCs.
(D) Top left: Socs3 expression in Nanog2/2 iNANOG+GY118F ESCs after induction with dox and/or GCSF in 2i. Top right: Socs3 expression in Nanog2/2
iNANOG+GY118F EpiSCs after induction with dox and/or GCSF in FGF2+ActivinA. Bottom: zoomed-in view of the respective dox inductions.
See also Figure S1.
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341augments LIF signal transduction in ESCs, resulting in higher
levels of active pSTAT3. The same trends were observed in
Nanog2/2 iNANOG+GY118F postimplantation epiblast stem
cells (EpiSCs) in standard FGF2+ActivinA conditions (Fig-
ure 1D), demonstrating that NANOG-mediated Socs3 repres-
sion is not restricted to ESCs and may be of functional
relevance during NANOG-driven reprogramming.
NANOG and pSTAT3 Synergistically Upregulate KLF4
To further explore our newfound mechanistic link between
NANOG and LIF/STAT3 signaling, we investigated the effect
of NANOG on expression of LIF/STAT3 targets in ESCs. Inthe steady-state presence of LIF, we found strong positive cor-
relation between levels of NANOG and KLF4, a canonical
pSTAT3 target [2, 7, 8] (Figures 1A and S1B). Interestingly, in
response to LIF stimulation, Klf4 upregulation required
NANOG to be present, while NANOG overexpression cooper-
ated with LIF to substantially increase the rate and levels of
Klf4 induction (Figures 2A and 2B). In agreement with previous
work [8], modest upregulation of NANOG was found in
response to LIF (Figures 1B and S2A).
The correlation between NANOG and Klf4 was abrogated
in the absence of pSTAT3 in Stat3+/+ ESCs without LIF and
in Stat32/2 ESCs (Figure 2C), showing that NANOG-driven
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Figure 2. NANOG and pSTAT3 Synergistically Upregulate KLF4
qRT-PCR analysis of gene expression relative to Gapdh and normalized to the highest value. Data shown are the mean of three technical replicates and are
from one of two representative experiments. Error bars indicate 6SD.
(A) Klf4 andK4eRNA expression inNanog2/2, wild-type, and constitutively NANOG-overexpressing ESCs in response to LIF stimulation. LIF was withdrawn
from serum culture for 36 hr prior to readdition. Selection for pluripotent cells was maintained throughout.
(B) Klf4 expression in Stat32/2, Nanog2/2, and wild-type ESCs in response to LIF stimulation. LIF was added after at least 7 days in 2i without LIF.
(C) Top: Klf4 and K4eRNA expression in NANOG-overexpressing Stat32/2, NANOG-overexpressing Stat3+/+, and STAT3-hyperactivated (GCSF/GY118F)
Nanog2/2 ESCs in basic conditions with or without LIF. Socs3 expression indicates STAT3 activation as appropriate. Bottom: Klf4 and K4eRNA expression
in Nanog2/2, wild-type, and constitutively NANOG-overexpressing ESCs cultured in steady-state serum+LIF.
(D) Klf4 and K4eRNA expression in Nanog2/2 iNANOG+GY118F ESCs after induction with dox and/or GCSF in 2i.
See also Figure S2.
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342Klf4 upregulation was pSTAT3 dependent. However, the
effect of NANOG on Klf4 transcription was not solely attribut-
able to pSTAT3 elevation, since STAT3 hyperactivation in
the absence of NANOG could not rescue Klf4 expression
(Figure 2C).
The relationship betweenNANOG, pSTAT3, andKlf4 expres-
sion was further dissected using Nanog2/2 iNANOG+GY118F
ESCs in 2i without LIF. Together, induction of NANOG expres-
sion and STAT3 activation elicited Klf4 upregulation in a syner-
gistic manner compared to induction of either factor alone
(Figure 2D). This synergistic action of NANOG and pSTAT3 is
specific to Klf4: other pluripotency factors did not respond in
this striking manner, including NANOG-target Esrrb [25] and
pSTAT3-target Klf5 [7, 8] (Figure S2B).
Since NANOG and pSTAT3 both bind the Klf4 enhancer (Fig-
ure S2C), it is likely that they regulate Klf4 transcription
directly. The Klf4 enhancer lies around 60 kb downstream of
the Klf4 transcription start site and was recently identified as
an archetypal ‘‘super-enhancer’’ [26]. We found novel noncod-
ing RNA to be expressed from the Klf4 enhancer in ESCs, andwe termed it K4eRNA (Figure S2C). Given that K4eRNA
expression positively correlates with Klf4, responding to
NANOG and LIF/STAT3 in the same synergistic manner (Fig-
ures 2A, 2C, and 2D), we hypothesize thatK4eRNA is a cis acti-
vator of Klf4 transcription.
NANOG and pSTAT3 Induce Rapid and Efficient
Reactivation of Naive Genes
EpiSC reprogramming requires reversion from primed to naive
pluripotency and thus provides an excellent system inwhich to
study naive pluripotency acquisition. Conversion of EpiSCs to
iPSCs does not occur simply in naive-state culture conditions,
but can be driven by a minimum of one factor [27]. It is known
that NANOG overexpression and STAT3 hyperactivation
together increase EpiSC reprogramming efficiency in a syner-
gistic manner [1]. Since we have mechanistically linked
NANOG and pSTAT3 in ESCs where the pluripotency network
is fully operational, we turned to EpiSCs to study the role of
these connected mechanisms during naive pluripotency
establishment.
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Figure 3. NANOG and pSTAT3 Induce Rapid and Efficient Reactivation of Naive Genes
(A) qRT-PCR analysis of Nanog2/2 and Nanog+/Flox (Nanog+/F) EpiSCs derived from Nanog2/F and Nanog+/F littermate embryos, cultured in FGF2+ActivinA
(F+A), compared to wild-type ESCs in 2i+LIF. Lack ofNanog expression inNanog2/2 EpiSCs confirmed the null genotype, while their expression ofOct4 and
Fgf5 but notRex1 or Klf4 confirmed their EpiSC identity. Gene expression wasmeasured relative toGapdh and normalized to the highest value. Data shown
are the mean of three technical replicates and are from one of two representative experiments. Error bars indicate 6SD.
(B) Representative phase and Nanog-GFP images of the Nanog2/2 EpiSCs derived from Nanog2/F embryos, in FGF2+ActivinA conditions. GFP reporter is
under the endogenous Nanog promoter of the floxed null allele (Figure S3A). Images are 1122 mm by 839 mm.
(C) qRT-PCR analysis of Klf4, K4eRNA, Klf5, Tfcp2l1, Esrrb, and Rex1 expression in Nanog2/2 iNANOG+GY118F EpiSCs after induction with dox and/or
GCSF in FGF2+ActivinA. Gene expression was measured relative to Gapdh and normalized to serum+LIF ESC level = 1. Data shown are the mean of three
technical replicates and are from one of two representative experiments. Error bars indicate 6SD.
See also Figure S3.
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343The iNANOG+GY118F system provides a powerful platform
for the quantitative dissection of NANOG and pSTAT3 mecha-
nisms, as they can be induced separately and in combination
within a single cell line. We generated Nanog2/2 background
EpiSCs (Figure 3A, 3B, and S3A–S3C) to eliminate confounding
endogenous Nanog expression, and maintained EpiSC
FGF2+ActivinA culture conditions so that putative reprogram-
ming kinetics could be ascribed exclusively to transgene
induction. Strikingly, NANOG and pSTAT3 codependently
reactivated Klf4 and K4eRNA in this distinct cellular and envi-
ronmental context (Figure 3C). This demonstrates that their
effect on Klf4 is not an ESC-specific phenomenon and may
be of functional relevance for NANOG/pSTAT3-driven reprog-
ramming. We observed activation of naive pluripotency
marker Rex1 at 48 hr (Figure 3C). Since Rex1 did not respond
to NANOG/pSTAT3 in this manner in ESCs (Figure S2B),
we believe Rex1 induction in EpiSCs to be indirect, indicating
identity changes toward iPSCs within the population.
Interestingly, Rex1 activation positively correlates with Klf4
expression.
Known NANOG-target Esrrb [25] responded to dox induc-
tion of NANOG expression in EpiSCs (Figure 3C). Similarly,
known pSTAT3 targets Klf5 [7, 8] and Tfcp2l1 [15, 28] were up-
regulatedafterGCSF inductionofSTAT3activation (Figure 3C).
However, the synergistic response of Klf4 to NANOG and
pSTAT3 remains unique. In total, NANOG and pSTAT3 rapidly
reactivated many key components of the naive pluripotencynetwork to near ESC level, shedding light on their ability to
drive fast and efficient reprogramming. This is even more
remarkable when taking into account that the assay used
EpiSC culture conditions instead of conditions promoting re-
programming or ESC self-renewal.
Combined pSTAT3 and KLF4 Bypass NANOG in
Reprogramming
Although NANOG is dispensable for pluripotencymaintenance
[11], it is required for establishment of the pluripotent
epiblast during preimplantation embryonic development [4].
Correspondingly, NANOG is essential for naive pluripotency
establishment during conventional in vitro reprogramming ex-
periments [4]. Rescue of Nanog2/2 reprogramming thus pro-
vides a means of functionally testing proposed downstream
mechanisms of NANOG.
We have described two new NANOG mechanisms: pSTAT3
elevation by SOCS3 repression and KLF4 upregulation in
cooperation with pSTAT3. Therefore, we investigated the abil-
ity of pSTAT3 and KLF4 to rescue reprogramming ofNanog2/2
EpiSCs. We also tested ESRRB, since it has previously been
reported as a NANOG downstream target able to bypass
NANOG in reprogramming of ESC-derived EpiSCs [25].
Expression of GFP and bgeo under the control of endogenous
Nanog promoters provide visual and selective reporters in our
system, since EpiSCs cannot survive long-term in the reprog-
ramming culture conditions (Figure 4A).
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Figure 4. Combined pSTAT3 and KLF4 Bypass NANOG in Reprogramming
(A) Schematic depicting the protocol for reprogramming of Nanog2/2 EpiSCs containing bgeo and GFP reporters under the endogenous Nanog promoters
(Figure S3A). EpiSCs were plated in FGF2+ActivinA (F+A) and, after 1 day, medium was switched to chiron+LIF or 2i+LIF to prompt reprogramming. On
day 7, G418, FGFR inhibitor, and ALK inhibitor were added to select for emergent iPSCs. On day 12, iPSCs were passaged into 2i+LIF.
(B) Representative phase and Nanog-GFP images taken on day 12 of reprogramming in 2i+LIF. The mean number of GFP+ iPSC colonies is indicated as the
percentage of cells initially plated, 6SD (n = 3 biological replicates). Nanog2/2 iNANOG+GY118F EpiSCs generated GFP+ iPSCs in 2i+LIF only if dox or
dox+GCSF were supplied during reprogramming, to induce NANOG expression and STAT3 activation, respectively. Nanog2/2 EpiSCs with activated
STAT3 (GCSF/GY118F) and constitutive ESRRB or KLF4 expression did not generate GFP+ iPSCs in 2i+LIF.
(C) Representative phase and Nanog-GFP images taken on day 12 of reprogramming in chiron+LIF. Quantification of reprogramming efficiency by GFP+
colony counting was inappropriate in this case, since chiron+LIF is a permissive medium compared to 2i+LIF and yielded some GFP+ colonies that were
not true iPSCs. After passaging in 2i+LIF, clean GFP+ iPSC lines were obtained as indicated.
(D) qRT-PCR analysis of gene expression in chiron+LIF-derived Nanog2/2 iPSCs after passaging in 2i+LIF, compared to parental EpiSC lines in FGF2+
ActivinA (F+A) and wild-type and Nanog2/2 ESCs in 2i+LIF. Expression patterns of Nanog, Esrrb, and Klf4 verified the genotypes. Reprogramming to naive
iPSCs was confirmed by reactivation of naive genes, maintenance of Oct4, and repression of Fgf5 expression. Gene expression was measured relative to
Gapdh and normalized to wild-type ESC level, except Fgf5, which was normalized to control EpiSCs. Data shown are the mean of three technical replicates
and are from one of two representative experiments. Error bars indicate 6SD.
(E) Chimericmouse obtained after injection of pSTAT3+KLF4 EpiSC-derivedNanog2/2 iPSCs intoC57/BL6 blastocysts. Agouti coat color indicates chimeric
contribution (MF1/129 background).
See also Figure S4.
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344Forced expression of NANOG, ESRRB, KLF4 or pSTAT3
individually can drive reprogramming of Nanog+/+ EpiSCs in
2i+LIF conditions [1, 4, 25, 27]. We verified the ability of our
Nanog2/2 EpiSCs to generate iPSCs in 2i+LIF when rescuedby NANOG expression and confirmed that STAT3 activation
in conjunction with NANOG expression drives rapid reprog-
ramming at high efficiency (Figure 4B). However, in the
absence of NANOG, individual and combined overexpression
Combined pSTAT3+KLF4 Bypass NANOG in Reprogramming
345of ESRRB, KLF4, and pSTAT3 could not rescue reprogram-
ming in 2i+LIF (Figure 4B).
In parallel, we tried to rescue Nanog2/2 reprogramming with
individual and combined overexpression of ESRRB, KLF4, and
pSTAT3 in chiron+LIF (Figure 4C) and in serum+LIF (data not
shown). To our surprise, we found that ESRRB overexpression
was unable to drive Nanog2/2 EpiSC reprogramming in any
condition. We speculate that this is due to differences in re-
programming propensity between our EpiSCs derived from
Nanog2/F embryos and ESC-derived secondary EpiSC sys-
tems [25]. Individually, KLF4 and pSTAT3 also failed to yield
iPSCs. Although they initially generated GFP+ colonies in
chiron+LIF (Figure 4C), these lacked the capacity to self-renew
after passaging into 2i+LIF, suggesting that reprogramming
was incomplete.
In combination, pSTAT3+ESRRB and pSTAT3+KLF4 yielded
Nanog2/2 GFP+ iPSCs in chiron+LIF conditions (Figure 4C).
Reprogramming occurred with the highest rate and efficiency
with pSTAT3+KLF4. Although Nanog2/2 iPSCs could not be
established in 2i+LIF, once naive pluripotency was established
in chiron+LIF, Nanog2/2 iPSCs could be passaged indefinitely
in 2i+LIF, consistent with known discrepancies between
NANOG requirement in pluripotency establishment versus
maintenance. After passaging in 2i+LIF, the gene expression
profile and observed chimeric competence ofNanog2/2 iPSCs
formally demonstrated their reacquisition of a naive pluripo-
tent program (Figures 4D and 4E). This highlights pSTAT3
activation as a key functional mechanism acting downstream
of NANOG, which, in conjunction with overexpression of
either NANOG-target KLF4 or ESRRB, can efficiently rescue
Nanog2/2 reprogramming. It is of interest to note that KLF4
but not NANOG overexpression can drive EpiSC reprogram-
ming in the presence of JAK inhibitor [1], further supporting
the placement of NANOG upstream and KLF4 downstream
of STAT3 activation during reprogramming.
NANOG is dispensable for the initial formation of repro-
gramming intermediates (pre-iPSCs) from somatic cells,
but is essential for pre-iPSCs to transit to naive pluripotency
in 2i+LIF [4] (confirmed in Figures S4A and S4B). Since
Nanog2/2 EpiSCs were able to reprogram in chiron+LIF but
not 2i+LIF, we tested whether Nanog2/2 pre-iPSCs could
also reprogram in alternative conditions. From these, we suc-
cessfully obtained Nanog2/2 iPSCs in chiron+LIF and
KSR+LIF conditions, albeit with low speed and efficiency (Fig-
ures S4C–S4E). Microarray analysis revealed that pre-iPSC-
derived and EpiSC-derived Nanog2/2 iPSCs clustered closely
with both wild-type and Nanog2/2 ESCs, demonstrating re-
programming to a naive pluripotent identity (Figure S4F). It
should be noted that retroviral Klf4 and exogenous LIF pro-
vided the reprogramming impetus for these pre-iPSCs, again
implicating pSTAT3 and KLF4 in the rescue of Nanog2/2
reprogramming.
Discussion
We connect NANOG with the activation of STAT3, two major
mechanisms for the establishment and maintenance of naive
pluripotency. Our finding that NANOGmodulates signal trans-
duction of extracellular cues adds a new dimension to the
interplay between external environment and nuclear control
networks to instate and reinforce cellular identity. We also pro-
vide mechanistic insight into the process of induced pluripo-
tency by showing that expression of KLF4, a canonical ‘‘Yama-
naka’’ factor, results from codependent and synergistic actionbetween NANOG and pSTAT3. Interestingly, the only remain-
ing factor to be used by all reprogramming protocols is LIF
and consequently STAT3 activation, now linked to NANOG.
The role of NANOG is thus to build a naive pluripotent
transcriptional network by concurrently inducing the expres-
sion of ESRRB, enhancing LIF/STAT3 signal transduction,
and inducing KLF4 expression in cooperation with pSTAT3
(Figure S4G). Ultimately, combinations of these factors allow
in vitro bypassing of NANOG for the establishment of a naive
pluripotent cell state. However, the observed slower kinetics
and reduced efficiency of Nanog2/2 somatic cell reprogram-
ming imply the existence of further mechanisms by which
NANOG operates. These may include additional downstream
effectors of reprogramming and the activities of NANOG co-
factors such as TET1/2 [29]. In this light, it is interesting to
note that bypass of NANOG in reprogramming was enhanced
by KSR medium (Figure S4C), which contains ascorbic acid, a
powerful coactivator of dioxygenases such as the jumonji
histone demethylases and TETs [30–34]. Additionally, it will
be of future interest to ascertain why 2i conditions are detri-
mental to Nanog2/2 reprogramming.
Successful induction of naive pluripotency can be achieved
by the combined actions of different culture environments with
different sets of transgenes. This has led to the notion that
iPSCs can be generated by different, independent reprogram-
ming mechanisms acting in an additive, linear manner. In
contrast to this, our newfound cooperative relationship be-
tween NANOG and STAT3 activity raises the possibility of an
integrated reprogrammingmechanism. Therefore, we propose
that allegedly independent mechanisms of naive pluripotency
inductionmay instead be linked and centered on a small group
of genes including NANOG.Accession Numbers
The Gene Expression Omnibus accession number for the microarray data
reported in this paper is GSE53529.Supplemental Information
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